تقرير
Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement.
| العنوان: | Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement. |
|---|---|
| المؤلفون: | van Lingen RG, van Erp PE, Seyger MM, de Jong EM, de Boer-van Huizen RT, Driessen RJ, van de Kerkhof PC |
| المصدر: | Acta dermato-venereologica [Acta Derm Venereol] 2009; Vol. 89 (5), pp. 518-20. |
| نوع المنشور: | Clinical Trial; Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: MJS Publishing Country of Publication: Sweden NLM ID: 0370310 Publication Model: Print Cited Medium: Internet ISSN: 1651-2057 (Electronic) Linking ISSN: 00015555 NLM ISO Abbreviation: Acta Derm Venereol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2024- : Uppsala, Sweden : MJS Publishing Original Publication: Stockholm : Acta dermato-venereologica |
| مواضيع طبية MeSH: | Antibodies, Monoclonal/*therapeutic use , Dermatologic Agents/*therapeutic use , Dipeptidyl Peptidase 4/*metabolism , Keratinocytes/*drug effects , Psoriasis/*drug therapy , T-Lymphocytes/*drug effects, Adult ; Biopsy ; Female ; Humans ; Infliximab ; Keratinocytes/immunology ; Keratinocytes/pathology ; Male ; Middle Aged ; Psoriasis/immunology ; Psoriasis/pathology ; Severity of Illness Index ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology ; Time Factors ; Treatment Outcome |
| المشرفين على المادة: | 0 (Antibodies, Monoclonal) 0 (Dermatologic Agents) B72HH48FLU (Infliximab) EC 3.4.14.5 (DPP4 protein, human) EC 3.4.14.5 (Dipeptidyl Peptidase 4) |
| تواريخ الأحداث: | Date Created: 20090908 Date Completed: 20091112 Latest Revision: 20151119 |
| رمز التحديث: | 20240628 |
| DOI: | 10.2340/00015555-0675 |
| PMID: | 19734982 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1651-2057 |
|---|---|
| DOI: | 10.2340/00015555-0675 |